Global Hemp Group Inc. (GHG.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.82 Million CAD | 57.99% |
| 2022 | 3.68 Million CAD | -31.22% |
| 2021 | 5.36 Million CAD | 255.26% |
| 2020 | 1.5 Million CAD | 234.9% |
| 2019 | 450.54 Thousand CAD | -23.14% |
| 2018 | 586.17 Thousand CAD | -9.55% |
| 2017 | 648.05 Thousand CAD | 33.47% |
| 2016 | 485.53 Thousand CAD | -18.9% |
| 2015 | 598.69 Thousand CAD | -62.39% |
| 2014 | 1.59 Million CAD | 4939.01% |
| 2013 | 31.59 Thousand CAD | -75.88% |
| 2012 | 130.94 Thousand CAD | 194.82% |
| 2011 | 44.41 Thousand CAD | -13.81% |
| 2010 | 51.53 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 6.12 Million CAD | 3.37% |
| 2024 Q1 | 5.88 Million CAD | 1.06% |
| 2024 Q2 | 5.92 Million CAD | 0.72% |
| 2023 FY | 5.82 Million CAD | 57.99% |
| 2023 Q1 | 3.76 Million CAD | 2.06% |
| 2023 Q2 | 4.11 Million CAD | 9.45% |
| 2023 Q3 | 4.22 Million CAD | 2.53% |
| 2023 Q4 | 5.82 Million CAD | 37.95% |
| 2022 Q2 | 5.43 Million CAD | 3.65% |
| 2022 Q4 | 3.68 Million CAD | -32.17% |
| 2022 Q3 | 5.43 Million CAD | 0.09% |
| 2022 FY | 3.68 Million CAD | -31.22% |
| 2022 Q1 | 5.23 Million CAD | -2.25% |
| 2021 Q1 | 1.15 Million CAD | -23.35% |
| 2021 FY | 5.36 Million CAD | 255.26% |
| 2021 Q4 | 5.36 Million CAD | -22.93% |
| 2021 Q3 | 6.95 Million CAD | 519.0% |
| 2021 Q2 | 1.12 Million CAD | -2.85% |
| 2020 Q2 | 425.57 Thousand CAD | -4.44% |
| 2020 Q1 | 445.33 Thousand CAD | -1.16% |
| 2020 FY | 1.5 Million CAD | 234.9% |
| 2020 Q4 | 1.5 Million CAD | 241.05% |
| 2020 Q3 | 442.42 Thousand CAD | 3.96% |
| 2019 FY | 450.54 Thousand CAD | -23.14% |
| 2019 Q4 | 450.54 Thousand CAD | 70.39% |
| 2019 Q1 | 321.25 Thousand CAD | -45.2% |
| 2019 Q2 | 266.15 Thousand CAD | -17.15% |
| 2019 Q3 | 264.42 Thousand CAD | -0.65% |
| 2018 Q2 | 266.56 Thousand CAD | -59.39% |
| 2018 Q1 | 656.35 Thousand CAD | 1.28% |
| 2018 Q4 | 586.17 Thousand CAD | 128.93% |
| 2018 FY | 586.17 Thousand CAD | -9.55% |
| 2018 Q3 | 256.04 Thousand CAD | -3.95% |
| 2017 Q4 | 648.05 Thousand CAD | 75.1% |
| 2017 Q1 | 374.9 Thousand CAD | -22.79% |
| 2017 Q2 | 373.85 Thousand CAD | -0.28% |
| 2017 FY | 648.05 Thousand CAD | 33.47% |
| 2017 Q3 | 370.09 Thousand CAD | -1.01% |
| 2016 Q1 | 523.4 Thousand CAD | -12.58% |
| 2016 Q3 | 512.69 Thousand CAD | -4.03% |
| 2016 Q4 | 485.53 Thousand CAD | -5.3% |
| 2016 FY | 485.53 Thousand CAD | -18.9% |
| 2016 Q2 | 534.24 Thousand CAD | 2.07% |
| 2015 Q3 | 1.77 Million CAD | 13.55% |
| 2015 Q1 | 1.45 Million CAD | -8.36% |
| 2015 Q2 | 1.56 Million CAD | 7.46% |
| 2015 FY | 598.69 Thousand CAD | -62.39% |
| 2015 Q4 | 598.69 Thousand CAD | -66.36% |
| 2014 Q3 | 259.65 Thousand CAD | -27.63% |
| 2014 Q1 | 66.13 Thousand CAD | 109.34% |
| 2014 FY | 1.59 Million CAD | 4939.01% |
| 2014 Q2 | 358.8 Thousand CAD | 442.55% |
| 2014 Q4 | 1.59 Million CAD | 513.07% |
| 2013 Q2 | 15.06 Thousand CAD | -89.48% |
| 2013 Q1 | 143.26 Thousand CAD | 9.4% |
| 2013 FY | 31.59 Thousand CAD | -75.88% |
| 2013 Q4 | 31.59 Thousand CAD | 130.02% |
| 2013 Q3 | 13.73 Thousand CAD | -8.85% |
| 2012 Q1 | 66.52 Thousand CAD | 49.76% |
| 2012 FY | 130.94 Thousand CAD | 194.82% |
| 2012 Q3 | 96.33 Thousand CAD | 0.91% |
| 2012 Q2 | 95.47 Thousand CAD | 43.52% |
| 2012 Q4 | 130.94 Thousand CAD | 35.93% |
| 2011 Q4 | 44.41 Thousand CAD | 132.27% |
| 2011 Q1 | 65.17 Thousand CAD | 0.0% |
| 2011 FY | 44.41 Thousand CAD | -13.81% |
| 2011 Q3 | 19.12 Thousand CAD | 30.09% |
| 2011 Q2 | 14.7 Thousand CAD | -77.44% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 FY | 51.53 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -98.37% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 59.319% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -1137.489% |
| The BC Bud Corporation | 626 Thousand CAD | -830.528% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 11.069% |
| CordovaCann Corp. | 11.29 Million CAD | 48.409% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 31.477% |
| Captor Capital Corp. | 28.76 Million CAD | 79.749% |
| City View Green Holdings Inc. | 3.73 Million CAD | -56.046% |
| 1CM Inc. | 9.42 Million CAD | 38.186% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 72.489% |
| IM Cannabis Corp. | 35.11 Million CAD | 83.41% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -136.831% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 42.216% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -2157.808% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -32.289% |
| Ovation Science Inc. | 728.99 Thousand CAD | -699.068% |
| Pharmadrug Inc. | 2.92 Million CAD | -99.118% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -178.854% |
| RAMM Pharma Corp. | 2.83 Million CAD | -105.435% |
| RIV Capital Inc. | 275.63 Million CAD | 97.887% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -71.13% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 98.402% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 84.5% |
| 1933 Industries Inc. | 23.28 Million CAD | 74.981% |
| Red Light Holland Corp. | 3.82 Million CAD | -52.425% |
| Top Strike Resources Corp. | 20.99 Million CAD | 72.253% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -637.402% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 67.011% |